Literature DB >> 11573978

Cell-specific expression and subcellular localization of neurophysin-CAT-fusion proteins expressed from oxytocin and vasopressin gene promoter-driven constructs in transgenic mice.

S W Jeong1, M Castel, B J Zhang, R L Fields, P Paras, H Arnheiter, H Chin, H Gainer.   

Abstract

The cell-specific expression of both the oxytocin (OT) and vasopressin (VP) genes in magnocellular neurons (MCNs) of the hypothalamus has been proposed to be under the control of cis-elements in an intergenic region downstream of the VP gene. We examined this hypothesis using transgenic mice containing mouse genomic DNA-derived constructs linked to chloramphenicol acetyltransferase (CAT) reporters. VP gene expression was studied using constructs containing 3.8 kbp of the 5' flanking region and all the exons and introns in the mouse VP gene, which was fused at the end of exon 3 to a CAT reporter. The two VP-transgene constructs differed by the lengths of their VP gene 3' flanking regions (2.1 versus 3.6 kbp). A similar construct for the oxytocin CAT transgene was used which contained the full-length (3.6 kbp) downstream intergenic region between the mouse genes. All three transgenic constructs produced cell-specific expression of the CAT-reporter in the magnocellular neurons as determined by CAT-immunoreactivity. Oxytocin transgene expression was restricted to OT cells in two founders, and the two VP transgenes to VP cells in five founders. Electron microscopic immunocytochemistry showed that the CAT fusion proteins produced from the OT- and VP-transgenes were efficiently trafficked through the regulated secretory pathways in their respective magnocellular neurons, packaged into large dense core vesicles, and transported to nerve terminals in the posterior pituitary. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11573978     DOI: 10.1006/exnr.2001.7785

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  7 in total

1.  Transgenic models for molecular and physiological studies in the central nervous system.

Authors:  Harold Gainer
Journal:  J Physiol       Date:  2003-06-17       Impact factor: 5.182

2.  Cell-type specific oxytocin gene expression from AAV delivered promoter deletion constructs into the rat supraoptic nucleus in vivo.

Authors:  Raymond L Fields; Todd A Ponzio; Makoto Kawasaki; Harold Gainer
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

Review 3.  Cell-type specific expression of oxytocin and vasopressin genes: an experimental odyssey.

Authors:  H Gainer
Journal:  J Neuroendocrinol       Date:  2012-04       Impact factor: 3.627

4.  Transgenesis and neuroendocrine physiology: a transgenic rat model expressing growth hormone in vasopressin neurones.

Authors:  Sara E Wells; David M Flavell; Gordon W Bisset; Pamela A Houston; Helen Christian; Keith M Fairhall; Iain C A F Robinson
Journal:  J Physiol       Date:  2003-06-17       Impact factor: 5.182

5.  Efficiency of cell-type specific and generic promoters in transducing oxytocin neurons and monitoring their neural activity during lactation.

Authors:  Keerthi Thirtamara Rajamani; Amanda B Leithead; Michelle Kim; Marie Barbier; Michael Peruggia; Kristi Niblo; Lara Barteczko; Arthur Lefevre; Valery Grinevich; Hala Harony-Nicolas
Journal:  Sci Rep       Date:  2021-11-18       Impact factor: 4.379

6.  Cell-type specific expression of the vasopressin gene analyzed by AAV mediated gene delivery of promoter deletion constructs into the rat SON in vivo.

Authors:  Todd A Ponzio; Raymond L Fields; Omar M Rashid; Yasmmyn D Salinas; Daniel Lubelski; Harold Gainer
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

Review 7.  Fluorescent visualization of oxytocin in the hypothalamo-neurohypophysial system.

Authors:  Hirofumi Hashimoto; Takanori Matsuura; Yoichi Ueta
Journal:  Front Neurosci       Date:  2014-07-23       Impact factor: 4.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.